UPDATE: AI Journalism Project Aigent Newsroom Joins Moltbook Platform – @aigent_news
• Public presence established on Moltbook social media under the handle @aigent_news • Project boasts 10x growing organic readership in the U.S., U.K.,…
UPDATE: UBS Reports $7.8 Billion Full-Year Profit, Hikes Dividend by 22%
• Full-year 2025 net profit reached USD 7.8 billion, with USD 1.2 billion in the fourth quarter. • Integration synergy target increased by…
UPDATE: UCB’s Bimzelx Shows Sustained Efficacy in Three-Year Skin Disease Study
• 40.1% of patients achieved total resolution of inflammatory lesions at year three. • Patients with severe hidradenitis suppurativa dropped from 87.4% at…
UPDATE: Tigerair Taiwan Orders Four Airbus A321neo Aircraft
• Order is for four A321neo aircraft. • Marks the airline’s first purchase agreement for this model. • New planes to feature a…
UPDATE: Qiagen Shows New High-Throughput Lab Automation System at SLAS 2026
• New QIAsprint Connect system can process up to 192 samples per run. • Company will also present QIAsymphony Connect for clinical labs…
UPDATE: Deutsche Börse Partners With Bitpanda on Digital Asset Services
• New collaboration combines 360T’s regulated 3DX platform with Bitpanda’s digital asset infrastructure. • Enables institutional clients to offer crypto services to end-users…
UPDATE: IKEA Electrify Heavy Transport in Italy
• IKEA Partners With Daimler Truck to Electrify Heavy Transport in Italy • Partnership includes IKEA, logistics firm LC3 Trasporti, and Mercedes-Benz Trucks.…
UPDATE: French Navy 1st to Receive Airbus’ Marine Drone
• French Navy to Receive New VTOL Version of Airbus’ Aliaca Drone • The French Directorate General of Armament (DGA) has ordered a…
UPDATE: French Authorities Raid X Paris Office, Summon Musk and Yaccarino
• The raid is part of a cybercrime investigation opened in January 2025. • Executives Elon Musk and Linda Yaccarino are summoned for…
UPDATE: FDA Grants Priority Review to Breast Cancer Drug Datroway
• The drug, Datroway, is for patients with metastatic triple-negative breast cancer not eligible for immunotherapy. • A pivotal trial showed the drug…